FdaApplication

NDA 208558

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTRAZENECA PHARMACEUTICALS LP
application_typeNDA
approval_date2017-08-17

Products (2)

ProductActive ingredientStrengthDosage form
LYNPARZAOLAPARIB150MGTABLET;ORAL
LYNPARZAOLAPARIB100MGTABLET;ORAL

2 products